Pfizer Doubts FDA Authority To Force Antihistamine OTC Switch
Executive Summary
FDA does not have the legal authority to force an OTC switch of a prescription antihistamine, Pfizer CEO Henry McKinnell told analysts on an April 18 conference call.
You may also be interested in...
Antihistamine Forced Switch To OTC Endorsed By APhA Journal Editorial
A Journal of the American Pharmaceutical Association editorial endorses the forced switch of prescription antihistamines to over-the-counter status.
Antihistamine Forced Switch To OTC Endorsed By APhA Journal Editorial
A Journal of the American Pharmaceutical Association editorial endorses the forced switch of prescription antihistamines to over-the-counter status.
Antihistamine OTC Switch: FDA Asking If Rx Products Have "Unique" Aspects
FDA regards the safety profiles of Rx antihistamines Claritin, Allegra and Zyrtec to be at least as good as currently marketed OTC antihistamines, briefing documents for the upcoming May 11 advisory committee meeting indicate.